| Literature DB >> 34648143 |
Yen-Chu Huang1, Jiann-Der Lee1, Yi-Ting Pan1, Hsu-Huei Weng2, Jen-Tsung Yang3, Leng-Chieh Lin4, Yuan-Hsiung Tsai5.
Abstract
The hemodynamic changes of acute small subcortical infarction (SSI) are not well understood. We evaluate the hemodynamic changes and collaterals in acute SSI using perfusion magnetic resonance imaging (MRI). A total of 103 patients with acute SSI in penetrating artery territories were recruited and underwent MRI within 24 h of stroke onset. Using 4D dynamic perfusion MRI, they were divided into three patterns: 25 (24%) with normal perfusion, 31 (30%) with compensated perfusion, and 47 (46%) with hypoperfusion. The development of anterograde or retrograde collaterals was also evaluated. Patients with hypoperfusion pattern had the highest rate of early neurological deterioration (32%, p = 0.007), the largest initial and final infarction volumes (p < 0.001 and p = 0.029), the lowest relative cerebral blood flow (0.63, p < 0.001), and the lowest rate of anterograde and retrograde collaterals (19%, p < 0.001; 66%, p = 0.002). The anterograde collaterals were associated with higher relative cerebral blood volume (0.91 vs. 0.77; p = 0.024) and a higher rate of deep cerebral microbleeds (48 vs. 21%; p = 0.028), whereas retrograde collaterals were associated with higher systolic and diastolic blood pressure (p = 0.031 and 0.020), smaller initial infarction volume (0.81 vs. 1.34 ml, p = 0.031), and a higher rate of lobar cerebral microbleeds (30 vs. 0%; p = 0.013). Both anterograde and retrograde collaterals may play a critical role in maintaining cerebral perfusion and can have an impact on patient clinical outcomes. Further studies are warranted to verify these findings and to investigate effective treatments.Entities:
Keywords: Early neurological deterioration; MRI; Perfusion defect; Small subcortical infarction; Small vessel disease
Mesh:
Year: 2021 PMID: 34648143 PMCID: PMC9046333 DOI: 10.1007/s12975-021-00953-x
Source DB: PubMed Journal: Transl Stroke Res ISSN: 1868-4483 Impact factor: 6.800
Fig. 1Illustration of different perfusion patterns in the represented patients. (A) An 89-year-old woman who had acute infarction in the left basal ganglia (arrow) on diffusion weighted imaging (DWI), with prolonged mean transit time (MTT, red arrowhead) and reduced cerebral blood flow (CBF, yellow arrowhead). The dynamic perfusion imaging showed a perfusion defect without collateral flow, which was classified as a hypoperfusion pattern. (B) A 76-year-old woman who had acute infarction in the left centrum semiovale on DWI (arrow) and a perfusion defect on MTT (red arrowhead) and CBF (yellow arrowhead). She was classified as having a hypoperfusion pattern, because of the delayed collateral flow without complete filling. (C) An 87-year-old man had acute infarction in the right basal ganglia on DWI (arrow) and a perfusion defect on MTT (red arrowhead) and CBF (yellow arrowhead). He was classified as having compensated perfusion because there was retrograde collateral flow with complete contrast filling. (D) An 86-year-old woman had acute infarction in the centrum semiovale on DWI (arrow) without visible perfusion defects. She was classified as having a normal perfusion pattern because of the normal perfusion
Fig. 2Illustration of patients with anterograde and retrograde collaterals. (A) A 76-year-old man had acute infarction in the right centrum semiovale (arrow) on diffusion weighted imaging (DWI), with prolonged mean transit time (MTT, red arrowhead) and reduced cerebral blood flow (CBF, yellow arrowhead). The dynamic perfusion imaging showed a perfusion defect (red circle) with anterograde collateral flows (star), which was present as a decreased signal in the center. (B) A 79-year-old man had acute infarction in the right basal ganglia on DWI (arrow) and a perfusion defect on MTT (red arrowhead) and CBF (yellow arrowhead). Dynamic perfusion imaging showed a perfusion defect (red circle) with retrograde collaterals (star), which was present as a decreased signal at the periphery of the circle (star)
Correlations between the collateral patterns and the baseline characteristics, imaging findings, and outcomes
| Characteristics | Anterograde | No anterograde | Retrograde | No retrograde | ||
|---|---|---|---|---|---|---|
| Age, median (IQR) | 70 (59.5–75.3) | 71 (61–78.8) | 0.385 | 70 (60.5–76.5) | 71 (61–78.5) | 0.701 |
| Female gender, n (%) | 10 (33%) | 21 (44%) | 0.360 | 21 (37%) | 10 (48%) | 0.388 |
| Diabetes mellitus, n (%) | 15(50%) | 32 (67%) | 0.143 | 33 (58%) | 14 (67%) | 0.483 |
| Hypertension, n (%) | 23 (77%) | 45 (94%) | 0.039 | 49 (86%) | 19 (90%) | 0.721 |
| Hypercholesterolemia, n (%) | 17 (57%) | 26 (54%) | 0.829 | 31 (54%) | 12 (57%) | 0.828 |
| Atrial fibrillation, n (%) | 2 (7%) | 2 (4%) | 0.626 | 4 (7%) | 0 (0%) | 0.569 |
| Previous antiplatelet use, n (%) | 4 (13%) | 6 (13%) | 1.000 | 7 (12%) | 3 (14%) | 1.000 |
| SBP (mmHg), mean ± SD | 176 ± 33 | 188 ± 33 | 0.143 | 187 ± 35 | 171 ± 25 | 0.031 |
| DBP (mmHg), mean ± SD | 103 ± 18 | 104 ± 19 | 0.828 | 106 ± 18 | 96 ± 16 | 0.020 |
| Sugar (mg/dL), median (IQR) | 137 (117–174) | 157 (118–214) | 0.386 | 139 (113–213) | 154 (127–178) | 0.800 |
| Creatinine clearance (cc/min), mean ± SD | 76 ± 32 | 71 ± 27 | 0.457 | 74 ± 27 | 71 ± 34 | 0.687 |
| Total cholesterol (mg/dL), mean ± SD | 188 ± 43 | 183 ± 41 | 0.628 | 184 ± 37 | 186 ± 54 | 0.842 |
| Baseline NIHSS, median (IQR) | 4 (3–6) | 5 (3–6) | 0.520 | 5 (3.5–6) | 4 (2.5–7) | 0.833 |
| NIHSS score on 3rd day, median (IQR) | 3.5 (2–6) | 4 (2.25–6) | 0.446 | 4 (2.5–6) | 4 (2–6) | 0.382 |
| END (NIHSS > 2), n (%) | 8 (27%) | 14 (29%) | 0.811 | 19 (33%) | 3 (14%) | 0.155 |
| Initial infarct volume (ml), median (IQR) | 1.0 (0.55–1.78) | 0.96 (0.48–1.73) | 0.869 | 0.81 (0.43–1.45) | 1.34 (0.62–3.2) | 0.031 |
| Final infarct volume (ml), median (IQR) | 1.52 (0.67–3.00) | 1.21 (0.79–2.47) | 0.728 | 1.27 (0.72–2.49) | 1.28 (0.82–3.35) | 0.452 |
| mRS at 3 months (IQR) | 1 (0–3) | 1 (0–3) | 0.755 | 1 (0–3) | 0 (0–3) | 0.141 |
| mRS≧3 at 3 months, n (%) | 10 (33.3%) | 13 (27.1%) | 0.556 | 17 (29.8%) | 6 (28.6%) | 0.914 |
| Onset-MRI duration (hour), median (IQR) | 12.6 (6.8–21.9) | 20.2 (13.2–23.0) | 0.020 | 16.7 (10.4–22.4) | 21.1 (10.8–23.0) | 0.600 |
| Branch atheromatous disease | 17 (57%) | 24 (50%) | 0.566 | 28 (49%) | 13 (62%) | 0.316 |
| Brainstem, n (%) | 1 (3%) | 11 (23%) | 0.024 | 8 (14%) | 4 (19%) | 0.724 |
| rCBF, median (IQR) | 0.69 (0.49–0.95) | 0.66 (0.43–0.81) | 0.408 | 0.65 (0.46–0.86) | 0.70 (0.39–0.82) | 0.787 |
| rCBV, median (IQR) | 0.91 (0.77–1.10) | 0.77 (0.58–0.97) | 0.024 | 0.84 (0.66–1.04) | 0.86 (0.58–0.99) | 0.669 |
| rMTT, median (IQR) | 1.93 (1.37–2.75) | 1.34 (1.12–1.99) | 0.016 | 1.71 (1.12–2.24) | 1.52 (1.06–2.35) | 0.702 |
| WMH scores of periventricular area (IQR) | 1 (1–2) | 1 (1–2) | 0.888 | 1 (1–2) | 1 (1–2) | 0.208 |
| WMH scores of basal ganglia (IQR) | 2 (1–2.25) | 2 (1–2) | 0.931 | 2 (1–2) | 2 (1–2) | 0.925 |
| EPVS scores of centrum semiovale (IQR) | 2 (1.75–3) | 2 (2–3) | 0.894 | 2 (2–3) | 2 (1–2.5) | 0.356 |
| EPVS scores of basal ganglia (IQR) | 2 (1–3) | 2 (1–2) | 0.420 | 2 (1–3) | 2 (1–2) | 0.379 |
| Lacune at centrum semiovale, n (%) | 7 (23.3%) | 12 (25.0%) | 0.868 | 15 (26.3%) | 4 (19.0%) | 0.507 |
| Lacune at basal ganglia, n (%) | 16 (53.3%) | 29 (60.4%) | 0.538 | 33 (57.9%) | 12 (57.1%) | 0.952 |
| CMBs at lobar areas, n (%) b | 9 (33%) | 4 (12%) | 0.063 | 13 (30%) | 0 (0%) | 0.013 |
| CMBs at deep areas, n (%) b | 13 (48.1%) | 7 (21.2%) | 0.028 | 16 (36.4%) | 4 (25.0%) | 0.541 |
| CMBs at infratentorial area, n (%) b | 4 (14.8%) | 5 (15.2%) | 1.000 | 8 (18.2%) | 1 (6.3%) | 0.422 |
a Creatinine clearance was estimated by the Cockcroft-Gault equation
b CMB data was unavailable in 18 patients
CMBs, cerebral microbleeds; END, early neurological deterioration; DBP, diastolic blood pressure; IQR, interquartile range; MRI, magnetic resonance imaging; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; SD, standard deviation
Fig. 3Illustration of different perfusion patterns with or without anterograde collaterals. (A) The retrograde (blue arrows) and anterograde (yellow arrows) were markedly decreased and a hypoperfusion pattern was observed. (B) The anterograde collaterals were significant reduced and perfusion depended on the retrograde collaterals. This was observed in both hypoperfusion and compensated perfusion patterns. (C) The anterograde collateral was prominent and this pattern was observed more often in compensated perfusion and less often in hypoperfusion patterns. (D) Both anterograde and retrograde collaterals were present, representing a normal perfusion pattern. This illustration was
modified from the figure by Rudilosso et al. [14]
Correlations between perfusion patterns and baseline characteristics, imaging findings, and outcomes
| Characteristic | Normal perfusion | Compensated perfusion | Hypoperfusion | |
|---|---|---|---|---|
| Age, median (IQR) | 71 (63–79.5) | 71 (60–77) | 70 (61–78) | 0.828 |
| Female gender, n (%) | 12 (48%) | 12 (39%) | 19 (40%) | 0.758 |
| Diabetes mellitus, n (%) | 13 (52%) | 16 (52%) | 31 (66%) | 0.348 |
| Hypertension, n (%) | 21 (84%) | 25 (81%) | 43 (91%) | 0.362 |
| Hypercholesterolemia, n (%) | 14 (56%) | 14 (45%) | 29 (62%) | 0.355 |
| Coronary artery disease, n (%) | 2 (8%) | 0 (0%) | 3 (6%) | 0.308 |
| Atrial fibrillation, n (%) | 2 (8%) | 2 (6%) | 2 (4%) | 0.799 |
| Previous antiplatelet use, n (%) | 4 (16%) | 2 (6%) | 8 (17%) | 0.379 |
| SBP (mmHg), mean ± SD | 173 ± 35 | 179 ± 34 | 186 ± 33 | 0.283 |
| DBP (mmHg), mean ± SD | 98 ± 19 | 102 ± 16 | 104 ± 20 | 0.424 |
| Sugar (mg/dL), median (IQR) | 132 (114–161) | 145 (120–197) | 139 (111–207) | 0.345 |
| Creatinine clearance (cc/min), mean ± SD | 62 ± 22 | 73 ± 31 | 73 ± 28 | 0.215 |
| Total cholesterol(mg/dL), mean ± SD | 182 ± 37 | 180 ± 41 | 188 ± 43 | 0.698 |
| Baseline NIHSS, median (IQR) | 3 (2–4.5) | 4 (4–6) | 5 (3–6) | 0.048 |
| NIHSS score on 3rd day, median (IQR) | 2 (1–4) | 3 (2–6) | 4 (3–7) | 0.002 |
| END (NIHSS > 2), n (%) | 0 (0%) | 7 (23%) | 15 (32%) | 0.007 |
| Initial infarct volume(ml), median (IQR) | 0.39 (0.23–0.78) | 0.81 (0.6–1.47) | 1.01 (0.44–2.35) | < 0.001 |
| Final infarct volume (ml), median (IQR) | 0.85 (0.38–1.47) | 1.06 (0.70–2.14) | 1.80 (0.81–2.64) | 0.029 |
| mRS at 3 months, median (IQR) | 1 (0–2) | 1 (0–2) | 1 (0–3) | 0.412 |
| mRS ≧ 3 at 3 months, n (%) | 6 (24.0%) | 6 (19.4%) | 17 (36.2%) | 0.235 |
| Onset-MRI duration (hour), median (IQR) | 16.0 (9.9–21.1) | 14.8 (6.8–22.3) | 19.4 (13.1–23.0) | 0.199 |
| Brainstem, n (%) | 9 (36%) | 2 (6%) | 10 (21%) | 0.024 |
| Branch atheromatous disease, n (%) | 6 (24%) | 15 (48%) | 26 (55%) | 0.037 |
| rCBF, median (IQR) | 1.04 (0.93–1.16) | 0.76 (0.52–0.89) | 0.63 (0.43–0.81) | < 0.001 |
| rCBV, median (IQR) | 1.01 (0.91–1.20) | 0.92 (0.76–1.05) | 0.77 (0.56–0.97) | 0.001 |
| rMTT, median (IQR) | 1.01 (0.97–1.12) | 1.72 (1.22–2.18) | 1.51 (1.12–2.26) | < 0.001 |
| Anterograde collaterals, n (%) | 25 (100%) | 21 (68%) | 19 (40%) | < 0.001 |
| Retrograde collaterals, n (%) | 25 (100%) | 26 (84%) | 31 (66%) | 0.002 |
| WMH scores of periventricular area, median (IQR) | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.872 |
| WMH scores of basal ganglia, median (IQR) | 1 (0–2) | 2 (1–2) | 2 (1–2) | 0.068 |
| EPVS scores of centrum semiovale, median (IQR) | 2 (2–2) | 2 (2–2) | 2 (2–3) | 0.890 |
| EPVS scores of basal ganglia, median (IQR) | 2 (1–2) | 2 (1–3) | 2 (2–2) | 0.171 |
| Lacune at centrum semiovale, n (%) | 5 (20.0%) | 8 (25.8%) | 11 (23.4%) | 0.877 |
| Lacune at basal ganglia, n (%) | 14 (56.0%) | 15 (48.4%) | 30 (63.8%) | 0.398 |
| CMBs at lobar areas, n (%) b | 3 (14%) | 6 (24%) | 7 (20%) | 0.667 |
| CMBs at deep areas, n (%) b | 3 (13.6%) | 7 (28.0%) | 8 (22.9%) | 0.487 |
| CMBs at infratentorial areas, n (%) b | 5 (22.7%) | 4 (16.0%) | 5 (14.3%) | 0.701 |
a Creatinine clearance was estimated by the Cockcroft-Gault equation
b CMB data was unavailable in 21 patients
CMBs, cerebral microbleeds; END, early neurological deterioration; DBP, diastolic blood pressure; IQR, interquartile range; MRI, magnetic resonance imaging; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; SD, standard deviation